Annual Meeting Program

(1)

S121

THURSDAY, OCTOBER 8, 2009

6–7:30 a.m. Industry-Sponsored Breakfast Symposium

7:30 a.m. Opening Session

Anne-Marie Houle, _{Northeastern Section President} Anton J. Bueschen

American Urological Association President

7:45–9:45 a.m. Plenary I

7:45 a.m. Welcome and Introduction

7:50 a.m. Erectile Dysfunction (ED) after Radical Prostatectomy

Francesco Montorsi

Università Vita Salute, Milan, Italy

Gerald Brock

London, ON, Canada

8:40 a.m. Locally Advanced and Metastatic RCC

John Fitzpatrick

Mater Misericordial Hospital, Dublin, Ireland

9:45–10:15 a.m. Break

10:15 a.m.–Noon Concurrent Poster Sessions

10:15–10:45 a.m. View Posters

10:45–11 a.m. Welcome and Introduction

11 a.m.–Noon Moderated Poster Session I: Prostate Cancer

11 a.m. P1. Pelvic Radiation in Patients with a Pelvic Kidney: No Longer Playing with Fire

David M. Berlach, Marylene Brodeur, DABR, Fabio Cury

McGill University, Montréal, QC, Canada

11:03 a.m. P2. Management of Prostate Cancer Following Solid Organ Transplantation

Jeff Larson, Jeffrey J. Tomaszewski, Marc C. Smaldone, Stephen V. Jackman

University of Pittsburgh School of Medicine, Pittsburgh, PA, United States

11:06 a.m. P3. A Systematic Analysis of the Detrimental Effect of Orchiectomy on 12 Systemic Morbidities

Valerie Deslauriers1_{, Hendrik Isbarn}1_{, Claudio Jeldres}1_,

Giovanni Lughezzani1_{, Maxine Sun}1_{, Philippe Arjane}1_,

Hugues Widmer1_{, Daniel Pharand}1_{, Francesco}

Montorsi2_{, Paul Perrotte}1_{, Pierre I. Karakiewicz}1

1_{University of Montréal, Montréal, QC, Canada;}2

Vita-Salute University, Milan, Italy

11:09 a.m. P4. A Systematic Analysis of the Detrimental Effect of Orchiectomy on Four Skeletal Morbidities

Claudio Jeldres1_{, Umberto Capitanio}1_{, Hendrik Isbarn}1_,

Giovanni Lughezzani1_{, Shahrokh F. Shariat}1_{, Maxine}

Sun1_{, Daniel Pharand}1_{, Hugues Widmer}1_{, Philippe}

Arjane1_{, Francesco Montorsi}2_{, Paul Perrotte}1_{, Pierre}

I. Karakiewicz1

Vita-Salute San Raffaele, Milan, Italy

11:12 a.m. P5. External Validation of a Postoperative Nomogram Predicting the Probability of Prostate Cancer Recurrence After Radical Prostatectomy

Lars Budäus1_{, Hendrik Isbarn}2_{, Felix F. K. Chun}3_,

Caludio Jeldres1_{, Sascha A. Ahyai}3_{, Thomas Steuber}2_,

Roman Heuer3_{, Mario Zacharias}3_{, Thorsten Schlomm}2_,

Georg Salomon2_{, Alexander Haese}2_{, Hans Heinzer}2_,

Hartwig Huland2_{, Markus Graefen}2_{, Pierre I.}

Karakiewicz1

1_{University of Montréal, Montréal, QC, Canada;} 2_{Martiniclinic, Prostate Cancer Center}

Hamburg-Eppendorf, Hamburg, Germany; 3_{University Hospital}

Hamburg-Eppendorf, Hamburg, Germany

11:15 a.m. P6. National Patterns of Diagnosis and Treatment of Localized Prostate Cancer at Veterans Administration Medical Centers

Ross Bauer, William Conners, Badar Mian

Stratton VA Medical Center, Albany, NY, United States.

11:18 a.m. P7. The Impact of Surgeon Fatigue on Performance of Open Radical Retropubic Prostatectomy

Marc C. Smaldone, Jeffrey J. Tomaszewski, Joel B. Nelson

University of Pittsburgh Medical Center, Pittsburgh, PA, United States

11:21 a.m. P8. Clinical Results of Long-Term Follow-up of a Large Active Surveillance Cohort

Laurence Klotz, Adam Lam, Alex Mladenov, Gerard Morton, Andrew Loblaw

Sunnybrook HSC, Toronto, ON, Canada

11:24 a.m. P9. Racial Differences in Risk Perception and Receipt of PSA Testing

Willie Underwood III1_{, Vickie L. Shavers}2_{, Richard}

P. Moser2

1_{Roswell Park Cancer Institute, Buffalo, NY, United}

States; 2_{National Cancer Institute, Bethesda, MD,}

United States

11:27 a.m. P10. High-Grade Prostatic Intraepithelial Neoplasia (HG-PIN) on Initial Prostate Biopsy is not a Risk Factor for Prostate Cancer at Repeat Biopsy

Lars Budäus1_{, Christopher R. Porter}2_{, Claudio Jeldres}1_,

Kora Tang3_{, Sascha A. Ahyai}4_{, Felix K. H. Chun}4_,

Northeastern Section AUA

(2)

S122 CUAJ • October 2009 • Volume 3(5Suppl3) Hendrik Isbarn3_{, Georg Salomon}3_{, Thorsten}

Schlomm3_{, Alexander Haese}3_{, Thomas Steuber}3_,

Hans Heinzer3_{, Hartwig Huland}3_{, Markus Graefen}3_,

Pierre I. Karakiewicz1_.

1_{University of Montréal, Montréal, QC, Canada;} 2_{Virginia Mason Medical Center, Seattle, WA, United}

States; 3_{Martiniclinic, Prostate Cancer Center}

Hamburg-Eppendorf, Hamburg, Germany; University Hospital Hamburg-Eppendorf, Hamburg, Germany

11:30 a.m. P11. Unilateral Prostate Cancer Cannot Be Reliably and Accurately Diagnosed with Systematic 10 or More Core Biopsy

Lars Budäus1_{, Hendrik Isbarn}2_{, Claudio Jeldres}1_,

Sascha A. Ahyai3_{, Thorsten Schlomm}2_{, Georg}

Salomon2_{, Hans Heinzer}2_{, Thomas Steuber}2_,

Alexander Haese2_{, Hartwig Huland}2_{, Markus}

Graefen2_{, Felix K. H. Chun}3_{, Pierre I. Karakiewicz}1

11:33 a.m. P12. Presence of Prostate Cancer at Saturation Biopsy Can Be Accurately Predicted

Lars Budäus1_{, Sascha A. Ahyai}2_{, Hendrik Isbarn}3_,Felix

K. H. Chun2_{, Matthias Reichert}2_{, Thomas Steuber}3_,

Hans Heinzer3_{, Georg Salomon}3_{, Paul Perrotte}1_,

Hartwig Huland3_{, Markus Graefen}3_{, Alexander}

Haese3_{, Pierre I. Karakiewicz}1

1_{University of Montréal, Montréal, QC, Canada;} 2_{University Hospital Hamburg-Eppendorf, Hamburg,}

Germany; 3_{Martiniclinic, Prostate Cancer Center}

11:36 a.m. P13. Are All Low-Risk Prostate Cancer Patients Created Equally?

Lars Budäus1_{, Hendrik Isbarn}2_{, Sascha A. Ahyai}3_,

Felix K. H. Chun3_{, Claudio Jeldres}1_{, Alexander Haese}2_,

Hans Heinzer2_{, Mario Zacharias}3_{, Roman Heuer}3_,

Thomas Steuber2_{, Georg Salomon}2_{, Thorsten}

Schlomm2_{, Paul Perrotte}1_{, Margit Fisch}3_{, Hartwig}

Huland2_{, Markus Graefen}2_{, Pierre I. Karakiewicz}1

11:39 a.m. P14. Withdrawn

11:42 a.m. P15. Comparison of Tertiary Center and Referred Prostate Biopsies: Impact of Re-Review on Gleason Score Accuracy

Michael A. Feuerstein1_{, Michael Hong}1_{, Tipu}

Nazeer2_{, Hugh Fisher}1_{, Ronald Kaufman, Jr.}1_{, Badar}

M. Mian2

1_{Albany Medical College, Albany, NY, United States;} 2_{Stratton VA Medical Center, Albany, NY, United}

States

11:45 a.m. P16. Systematic Assessment of Total Prostate-Specific Antigen (PSA) and Percentage-Free/Total PSA on the Rate of Biopsy Recommendation: A Population-Based Study

Al’a Abdo1_{, Laurent Zini}2_{, Umberto Capitanio}3_,

Hendrik Isbarn4_{, Claudio Jeldres}1_{, Shahrokh F.}

Shariat1_{, Georg Hutterer}1_{, Giovanni Lughezzani}1_,

Maxine Sun1_{, Francesco Montorsi}3_{, Paul Perrotte}1_,

Pierre I. Karakiewicz1

1_{University of Montréal, Montréal, QC, Canada;} 2_{Lille University Hospital, Lille, France;}3_{Vita Salute}

University San Raffaele, Milan, Italy; 4_{Martiniclinic,}

Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany

11:48 a.m. P17. Initial Experience with Prostate Brachytherapy: Ten-Year Results from a Single Surgeon at a Single Institution

Jonah S. Marshall, Allison L. Cardin, Eric A. Singer, Andrew Tompkins, Edwin van Wijngaarden, Paul Winters, Ralph Brassachio, Dragan Golijanin, Edward M. Messing

University of Rochester, Rochester, NY, United States

11:51 a.m. Discussion

Noon Adjourn

11 a.m.–Noon Moderated Poster Session II: Basic Research

11 a.m. P18. Evaluation of Hedgehog Signaling in Human Transitional Carcinoma Cell Lines

Clay W. Mechlin1_{, Matt Tanner}2_{, Badar Mian}3_{, Ralph}

Buttyan2

1_{Albany Medical Center, Albany, NY, United States;} 2_{Ordway Research Center, Albany, NY, United}

States; 3_{Albany Medical Center, Stratton VA Medical}

Center, Albany, NY, United States

11:03 a.m. P19. Effect of Neoplasia in the Urinary Tract on Urine Levels of CC Chemokines: A Cross-Sectional Study

Bruce L. Jacobs1_{, Yoram Vodovotz}1_{, Vikas Tyagi}1_,

Derek Barclay1_{, Stephen V. Jackman}1_{, Wendy W.}

Leng1_{, Pradeep Tyagi}2

1_{University of Pittsburgh, Pittsburgh, PA, United States;} 2_{William Beaumont, Royal Oak, MI, United States}

11:06 a.m. P20. Cannabinoid Receptors in Human Urothelial Carcinoma

Ruthie Su, Vikas Tyagi, Brian Phillips, Pradeep Tyagi, Naoki Yoshimura

University of Pittsburgh, Pittsburgh, PA, United States

11:09 a.m. P21. Prostate Cancer Progression Through the Fer Kinase, a Potent Regulator of Androgen Receptor Signaling

Joice Rocha, Amina Zoubeidi, Fatima Zouanat, Lucie Hamel, PhD, Eleonora Scarlata, Armen Aprikian, Simone Chevalier

McGill, Montréal, QC, Canada

11:12 a.m. P22. Effect of Combined EGFR Inhibition and PPAR Gamma-Agonist in Bladder Cancer Therapy

Jose J. Mansure, Konrad Szymanski, Roland Nassim, Joice Rocha, Saad AldoUnited Statesri, Saad AldoUnited Statesri, Simone Chevalier, Wassim Kassouf

McGill University Health Centre, Montréal, QC, Canada

11:15 a.m. P23. The FGFR3 Mutation is Related to Favorable pT1 Bladder Cancer

Bas W. G. van Rhijn1_{, Bharati Bapat}2_{, Theo H. van}

der Kwast1_{, Liyang Liu}3_{, Neil E. Fleshner}1_{, Madelon}

N. M. van der Aa4_{, Rati Vajpeyi}5_{, Chris H. Bangma}4_,

Ellen C. Zwarthoff6_{, Michael A. S. Jewett}1_{, Alexandre}

(3)

1_{University of Toronto, University Health Network,}

Toronto, ON, Canada; 2_{University of Toronto and}

Mount Sinai Hospital, Toronto, ON, Canada; 3_Mount

Sinai Hospital, Toronto, ON, Canada, 4_Josephine

Nefkens Institute, Erasmus MC, Rotterdam, Netherlands; 5_{University Health Network, Toronto,}

ON, Canada; 6_{Josephine Nefkens Institute, Erasmus}

MC, Rotterdam, Netherlands; 7_{University of Toronto,}

University Health Network and Mount Sinai Hospital, Toronto, ON, Canada

11:18 a.m. P24. Role of NF-kB in Bladder Carcinogenesis in the Rat

Ching Wang1_{, Katsumi Imaida}2_{, Taro Iguchi}3_{, Gabriel}

P. Haas1

1_{SUNY Upstate Medical University, Syracuse, NY,}

United States; 2_{Kagawa University Medical School,}

Kagawa, Japan; 3_{Osaka City University Medical}

School, Osaka, Japan

11:21 a.m. P25. Soy Isoflavone G-2535 and Bladder Cancer: Molecular Effects in Tumor Tissue and Urine

Edward Messing1_{, KyungMann Kim}2_{, Jason Gee}2_,

Daniel Saltzstein3_{, Robert Weiss}4_{, Jorge Yao}1_{, P.}

Anthony di’SantAgnese1_{, Howard Bailey}2

1_{University of Rochester, Rochester, NY, United}

States; 2_{University of Wisconsin–Madison, Madison,}

WI, United States; 3_{Urology San Antonio, San}

Antonio, TX, United States; 4_{Yale University School}

of Medicine, New Haven, CT, United States

11:24 a.m. P26. Reconstruction of an Autologous Urethral Model by Tissue Engineering

Gabrielle Ouellet, Geneviève Bernard, Stéphane Bolduc

Labortoire d’Organogénèse Expérimentale (LOEX), Québec, QC, Canada

11:27 a.m. P27. Effect of Varicocelectomy on Sperm Chromatin and DNA Integrity

Raed Azhar, Abdulaziz Baazeem, Maria San Gabriel, Armand Zini

11:30 a.m. P28. Pilot Study on WST11 Safety and Efficacy for Vascular Targeted Photodynamic Therapy in the Dog Prostate

Maurice Anidjar1_{, Eleonora Scarlata}1_{, Lucie}

Hamel1_{, Sabri Moussa}1_{, Konrad Szymanski}1_,

Mostafa Elhilali1_{, Avigdor Scherz}2_{, Herve Ficheux}3_,

Simone Chevalier1_.

1_{McGill University Health Centre-Research Institute,}

Montréal, QC, Canada; 2_{Weizmann Institute,}

Rehovot, Israel; 3_{STEBA, Paris, France}

11:33 a.m. P29. Regulation of Apoptosis in Renal Epithelial Cells by Annexin A1 During Mechanical Stress

Gavin M. Langillle, Binyou Zheng, Dawn L. MacLellan

Dalhousie University, Halifax, NS, Canada

11:36 a.m. P30. Specific NADP(H) Oxidase Inhibition Abrogates HIF Transactivation and the Tumorigenic Phenotype of Renal Cancer Cells

Guimin Chang, Zheng Hu, Jodi K. Maranchie

11:39 a.m. P31. Frequency Dependent Pudendal Neuromodulation and Opiate Receptor Involvement in the Pudendal-to-Bladder Reflex in Cats

Mang L. Chen1_{, Bing Shen}2_{, Jicheng Wang}1_{, Hailong}

Liu1_{, James R. Roppolo}2_{, William C. de Groat}2_,

Changfeng Tai2

1_{Department of Urology, University of Pittsburgh,}

Pittsburgh, PA, United States; 2_{Department of}

Pharmacology, University of Pittsburgh, Pittsburgh, PA, United States

11:42 a.m. P32. Early Induction of Erectile Dysfunction by Angiotensin II in the Rat

Robert L. Segal1_{, Frederic Mampouma}2_{, Taben M.}

Hale2_{, Serge Carrier}1_{, Denis deBlois}2

1_{McGill University, Montréal, QC, Canada;} 2_{Universite de Montréal, Montréal, QC, Canada}

11:45 a.m. P33. Peroxiredoxins: Novel Antioxidant Enzymes of Human Spermatozoa

Angela Souza, Cristian O’Flaherty

11:48 a.m. P34. Androgen Receptor (AR) and Bladder Cancer: A Large Bi-Institutional Study on 473 Patients

Carmen Mic1_{, Shahrokh Shariat}2_{, Theodorus Van}

der Kwast3_{, Raheela Ashfaq}4_{, Yair Lotan}4_{, Sean}

Skeldon3_{, Sally Hanna}3_{, Sultan AlKhateeb}3_{, Juan}

Morote1_{, Bas Van Rhijn}3_{, Neil Fleshner}3_{, Michael}

Jewett3_{, Alexandre R. Zlotta}3

1_{Hospital Clinic, Barcelona, Spain;}2_Memorial

Sloan-Kettering Cancer Center, New York,, NY, United States; 3_{University of Toronto, University Health}

Network, Toronto, ON, Canada; 4_{University of Texas,}

Southwestern Medical Center, Dallas, TX, United States

Noon Adjourn

Noon–1:30 p.m. Sneak Peek Luncheon in Exhibit Hall

1:30–2:45 p.m. Plenary Session II

1:30 p.m. Welcome and Introduction

1:35 p.m. Testosterone Supplementation and Its Risks

2:10 p.m. Prostatitis: A Phoenix Rising from the Ashes

J. Curtis Nickel

Kingston General Hospital, Kingston, ON, Canada

2:45–3:15 p.m. Break in Exhibit Hall

3:15–5 p.m. Concurrent Poster Sessions

3:15–3:45 p.m. View Posters

3:45–4 p.m. Welcome and Introduction

4–5 p.m. Moderated Poster Session III: Robotics, Endoscopy and Laparoscopy

(4)

S124 CUAJ • October 2009 • Volume 3(5Suppl3)

4 p.m. P35. A Multi-Centre Randomized Trial Comparing Bipolar vs. Monopolar Transurethral Resection of the Prostate

Carlos E. Mendez Probst, Linda Nott, Hassan Razvi

Schulich School of Medicine and Dentistry, London, ON, Canada

4:03 p.m. P36. Development and External Validation of a Highly Accurate Nomogram for the Prediction of Perioperative Mortality After Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia

Claudio Jeldres1_{, Hendrik Isbarn}2_{, Umberto}

Capitanio3_{, Laurent Zini}4_{, Naeem Bhojani}5_{, Shahrokh}

F. Shariat5_{, Vincent Cloutier}4_{, Jean-Baptiste Lattouf}5_,

Alain Duclos5_{, Martine Jolivet-Tremblay}5_{, Luc}

Valiquette5_{, Fred Saad}1_{, Markus Graefen}2_{, Francesco}

1_{University of Montréal Health Centre, Montréal,}

QC, Canada; 2_{Prostate Cancer Center}

Hamburg-Eppendorf, Hamburg, Germany; 3_{Vita-Salute San}

Raffaele, Milan, Italy; 4_{Lille University Hospital,}

Lille, France; 5_{University of Montréal, Montréal,}

QC, Canada

4:06 p.m. P37. Renal Access by Urologist or Radiologist During Percutaneous Nephrolithotomy

Jeffrey J. Tomaszewski, Marc C. Smaldone, Stephen V. Jackman, Timothy D. Averch

4:09 p.m. P38. Validation of Real-Time, Intra-Operative, Surgical

C_{ompetence (RISC) Assessments Linked to Patient}

Outcomes

Ethan D. Grober, Matthew Roberts, Mohammed Mahdi, Wonnie Shin, Michael AS Jewett

University of Toronto, Toronto, ON, Canada

4:12 p.m. P39. Can Human Anatomy be Taught Through the Lenses of a Virtual Reality Simulator?

Khurshid A. Guru1_{, Thenkurussi Kesavadas}2_{, Ankur}

Baheti2_{, Govindarajan Srimathveeravalli}2

States; 2_{State University of New York at Buffalo,}

Buffalo, NY, United States

4:15 p.m. P40. Does Prostate Size Matter? An Evaluation of Patients Undergoing Robot-Assisted Prostatectomy

Matthew M. Lux, Jorge Yao, Jean V. Joseph

4:18 p.m. P41. Does Obesity Affect Outcomes in Extraperitoneal Robot-Assisted Prostatectomies?

Matthew M. Lux, Tricia D. Greene, Jean V. Joseph

4:21 p.m. P42. Simplified Laparoscopic Partial Nephrectomy Using a Single-Layer Closure and No Bolsters for Central Renal Tumors

Matthew Hayn, Khurshid Guru, Hyung Kim

Roswell Park Cancer Institute, Buffalo, NY, United States

4:24 p.m. P43. Laparoscopic Nephroureterectomy Does Not Undermine Cancer Control Outcomes in Selected Patients with Non-Metastatic Upper Tract Urothelial Carcinoma: A Multi-Institutional Analysis of 1249 Cases

Al’a Abdo, Claudio Jeldres, Naeem Bhojani, Daniel Liberman, Fred Saad, Francois Benard, Luc

Valiquette, Paul Perrotte, Pierre I. Karakiewicz

University of Montréal, Montréal, QC, Canada

4:27 p.m. P44. Robotic-Assisted Transvesical Prostatectomy for Benign Prostatic Hypertrophy: Description of Technique and Operative and Post-Operative Data of Initial Series of Six Patients

Allison L. Cardin1_{, Eric A. Singer}1_{, Jonah Marshall}1_,

Dragan Golijanin1_{, John Valvo}2_{, Louis Eichel}2_,

Frederick Tonetti2

States; 2_{Rochester General Hospital, Rochester, NY,}

United States

4:30 p.m. P45. The Value of Transrectal Ultrasound in Predicting Prostate Weights and Outcomes Following Laparoscopic Radical Prostatectomy

Jason Kovac, Ayman Raees, Bobby Shayegan, John P. Whelan, Edward D. Matsumoto

McMaster University, Hamilton, ON, Canada

4:33 p.m. P46a. Robotics in Urology: Comparative International Contemporary Practice Patterns

Bertram Yuh1_{, Rameela Chandrasekhar}2_{, Abid}

Hussain2_{, Gregory Wilding}2_{, James Mohler}2_{, Mani}

Menon3_{, James Peabody}3_{, Khurshid Guru}2

1_{University of Buffalo, Buffalo, NY, United States;} 2_{Roswell Park Cancer Institute, Buffalo, NY, United}

States; 3_{Henry Ford Hospital, Detroit, MI, United}

States

P46b. Current Status of Robot-Assisted Surgery in Urology: A Multi-National Survey of 297 Urologic Surgeons

Khurshid A. Guru1_{, Rameela Chandrasekhar}2_{, Abid}

Hussain1_{, Pamela Piacente}1_{, Marlene Bienko}1_{, Mark}

Glasgow2_{, Willie Underwood}1_{, Gregory Wilding}2_,

James L. Mohler1_{, Mani Menon}3_{, James O. Peabody}3

States; 2_{State University of New York at Buffalo,}

Buffalo,NY, United States; 3_{Vattikuti Urology Institute,}

Henry Ford Hospital, Detroit, MI, United States

4:36 p.m. P47. Comparison of Extraperitoneal and Transperitoneal Robot-Assisted Radical Prostatectomy in the Obese Patient

Matthew M. Lux, Erdal Erturk, Jean V. Joseph

4:39 p.m. P48. Early Post-Operative Renal Scintigraphy as a Predictor of Long-Term Outcomes After Laparoscopic Pyeloplasties

Michel Hugues Lebel1_{, Frederic Pouliot}1_{, David}

Méthot-Langevin2_{, Jean-François Audet}1_{, Thierry}

Dujardin1

1_{Centre Hospitalier Universitaire de Québec,}

Québec, QC, Canada; 2_{Laval University, Québec,}

QC, Canada

4:42 p.m. P49. From Laparoscopic to Robotic-Assisted Pyeloplasty: Our Extended Experience

Bishoy A. Gayed, Bruce L. Jacobs, Tina K. Schuster, Timothy D. Averch

4:45 p.m. Discussion

(5)

4–5 p.m. Moderated Poster Session IV: Bladder Cancer

4 p.m. P50. A Comparative Survival Analysis of Nonbilharzial Squamous Cell Carcinoma vs. Transitional Cell Carcinoma After Radical Cystectomy

Nawar Hanna1_{, Claudio Jeldres}1_{, Sara}

Baillargeon-Gagne1_{, Hendrik Isbarn}1_{, Umberto Capitanio}1_,

Shahrokh F. Shariat1_{, Giovanni Lughezzani}1_{, Maxine}

Sun1_{, Fred Saad}1_{, Paul Perrotte}1_{, Francesco}

Montorsi2_{, Markus Graefen}3_{, Pierre I. Karakiewicz}1

1_{University of Montréal, Montréal, QC, Canada;} 2_{Vita-Salute San Raffaele, Milan, Italy;}3_{Martiniclinic,}

4:03 p.m. P51. mTOR Inhibitor RAD001 (everolimus) Has Significant Antitumor Activity in Bladder Cancer

Jose Mansure, Roland Nassim, Simone Chevalier, Joice Rocha, Eleonora Scarlata, Wassim Kassouf

4:06 p.m. P52. A Comparative Survival Analysis of Adenocarcinoma vs. Transitional Cell Carcinoma After Radical Cystectomy

Radoslav Krouchev1_{, Giovanni Lughezzani}1_{, Claudio}

Jeldres1_{, Sara Baillargeon-Gagne}1_{, Hendrik Isbarn}1_,

Daniel Liberman1_{, Paul Perrotte}1_{, Fred Saad}1_{, Luc}

Valiquette1_, _Francesco _Montorsi2_, _Pierre _I.

Karakiewicz1

1_{University of Montréal, Montréal, QC, Canada;} 2_{Vita Salute University San Raffaele, Milan, Italy}

4:09 p.m. P53. Combined Modality Treatment with Bladder Preservation for Muscle Invasive Bladder Cancer

Magdy A. Sabaa Sr.

Tants University, Tanta, Egypt

4:12 p.m. P54. A Population-Based Assessment of Perioperative Mortality After Cystectomy for Bladder Cancer

Claudio Jeldres1_{, Hendrik Isbarn}1_{, Laurent Zini}1_,

Paul Perrotte1_{, Sara Baillargeon-Gagne}1_{, Umberto}

Capitanio1_{, Shahrokh F. Shariat}1_{, Philippe Arjane}1_,

Fred Saad1_{, Michael McCormack}1_{, Luc Valiquette}1_,

Francois Peloquin1_{, Alain Duclos}1_{, Francesco}

Montorsi2_{, Markus Graefen}3_{, Pierre I. Karakiewicz}1

1_{University of Montréal, Montréal, QC, Canada;} 2_{Vita-Salute San Raffaele, Milan, Italy;}3_Prostate

Cancer Center Hamburg-Eppendorf, Hamburg, Germany

4:15 p.m. P55. Stage Distribution at Radical Cystectomy During the Last Two Decades

Al’a Abdo, Claudio Jeldres, Daniel Liberman, Naeem Bhojani, Fred Saad, Luc Valiquette, Paul Perrotte, Pierre I. Karakiewicz

University of Montréal, Montréal, QC, Canada

4:18 p.m. P56. The Incidence of Prostate Cancer and Urothelial Cancer in the Prostate in Cystoprostatectomy Specimens

Sri Sivalingam, Darrel Drachenberg

University of Manitoba, Winnipeg, MB, Canada

4:21 p.m. P57. Management and Outcome of Patients who had Unresectable Disease upon Exploratory Laparotomy for Bladder Cancer

Faysal A. Yafi, Marie Duclos, José A. Correa, Simon Tanguay, Armen G. Aprikian, Fabio Cury, Luis Souhami, Raghu Rajan, Wassim Kassouf

4:24 p.m. P58. Impact of Sub-Stage and Pathology Review on the Clinical Outcome of pT1 Bladder Cancer

Bas W. G. van Rhijn1_{, Theo H. van der Kwast}1_{, David}

Kakiashvili1_{, Neil E. Fleshner}1_{, Sultan Alkhateeb}1_,

Madelon N. M. van der Aa2_{, Rati Vajpeyi}3_{, Chris}

H. Bangma2_{, Michael A. S. Jewett}1_{, Alexandre R.}

Zlotta1

Toronto, ON, Canada; 2_{Josephine Nefkens Institute,}

Erasmus MC, Rotterdam, Netherlands; 3_University

Health Network, Toronto, ON, Canada

4:27 p.m. P59. Long-Term Follow-Up for Primary T1 High-Grade Bladder Cancer—Does BCG Really Prevent Progression?

David Kakiashvili1_{, Bas W. G. van Rhijn}1_{, Michael}

A. S. Jewett1_{, Neil E. Fleshner}1_{, Julian Azzuero}1_,

Alex Kostynskyy2_{, Chris H. Bangma}3_{, Theodorus}

H. Van Der Kwast1_{, Alexandre R. Zlotta}1

Toronto, ON, Canada; 2_{University Health Network,}

Toronto, ON, Canada; 3_{Josephine Nefkens Institute,}

Erasmus MC, Rotterdam, Netherlands

4:30 p.m. P60. What is the Long-Term Prognostic Value of Pro-Apoptotic, Anti-Pro-Apoptotic, Proliferation and Invasiveness Molecular Markers in Patients Treated with BCG for High-Risk Non-Muscle Invasive Bladder Cancer?

S. Alkhateeb1_{, MG Neill}1_{, B. Van Rhijn}1_{, D.}

Kakiashvili1_{, N. Fleshner}1_{, M. Jewett}1_{, S. Bar-Moshe}2_,

M. Petein2_{, C. Schulman}2_{, T. Roumeguere}2_{, S.}

Rorive2_{, Alexandre R. Zlotta}1

Toronto, ON, Canada; 2_{Erasme Hospital and}

University Clinics of Brussels, Brussels, Belgium

4:33 p.m. P61. Does Screening for Bladder Cancer Produce a Stage Migration Towards Non-Muscle Invasive Cancers?

Alexandre R. Zlotta1_{, T. Roumeguere}2_{, S. Alkhateeb}1_,

S. Rorive2_{, A. Lemy}2_{, I. Salmon}2_{, M. Wissing}2_{, D.}

Abramowicz2_{, C. Schulman}2_{, N. Fleshner}1_{, M.}

Jewett1_{, J. Nortier}2

Toronto, ON, Canada; 2_{Erasme Hospital and}

University Clinics of Brussels, Brussels, Belgium

4:36 p.m. P62. Cost Analysis of a Single Instillation of Mitomycin C After Transurethral Resection of Bladder Tumor in the Québec Health Care System

Robert L. Segal, Andrew Feifer, Xuanqian Xie, James M. Brophy, Wassim Kassouf

4:39 p.m. P63. Surveillance Guidelines Based on Recurrence Patterns Following Radical Cystectomy for Bladder Cancer: The Canadian Bladder Cancer Network Experience

Faysal A. Yafi1_{, Armen G. Aprikian}1_{, Yves Fradet}2_,

Joe Chin3_{, Jonathan Izawa}3_{, Ricardo Rendon}4_{, Eric}

(6)

Estey5_{, Adriane Fairey}5_{, Ilias Cagiannos}6_{, Louis}

Lacombe2_{, Jean-Baptiste Lattouf}7_{, David Bell}4_{, Darrel}

Drachenberg8_{, Wassim Kassouf}1

1_{McGill University, Montréal, QC, Canada,}2_Laval

University, Québec, QC, Canada; 3_{University of}

Western Ontario, London, ON, Canada; 4_Dalhousie

University,Halifax, NS, Canada; 5_{University of}

Alberta, Edmonton, AB, Canada; 6_{University of}

Ottawa, Ottawa, ON, Canada; 7_{University of}

Montréal, Montréal, QC, Canada; 8_{University of}

Manitoba, Winnipeg, MB, Canada

4:42 p.m. P64. Florescence Cystoscopy with Hexaminolevulinate (HAL) Improves Detection Rate of Ta and T1 Bladder Cancer and Reduces Recurrence Following TURBT at Nine Months

Edward Messing1_{, Yves Fradet}2_{, Alvaro Morales}3_,

Lance Mynderse4_{, Mark Soloway}5_{, Unyime Nseyo}6_,

Seth Lerner7_{, H. Barton Grossman}8

States; 2_{Laval University, Québec, QC, Canada;} 3_{Kingston General Hospital, Kingston, ON, Canada;} 4_{Mayo Clinic, Rochester, MN, United States;} 5_{University of Miami, Miami, FL, United States;} 6_{University of Florida, Gainesville, FL, United States;} 7_{Baylor College of Medicine, Houston, TX, United}

States; 8_{MD Anderson, Houston, TX, United States}

4:45 p.m. P65. Survey on the Work-Up and Screening of Hematuria Among General Practitioners in Québec

Faysal A. Yafi, Armen G. Aprikian, Simon Tanguay, Wassim Kassouf

4:48 p.m. P66. Combining mTOR Inhibitor (RAD001) with Ionizing Radiation: A Novel Strategy for the Treatment of Bladder Cancer

Roland Nassim1_{, Jose Joao Mansure}2_{, Simone}

Chevalier1_{, Fabio Cury}2_{, Wamied Abdul Rahman}2_,

Ismail Al-Dahlawi2_{, Wassim Kassouf}1

1_{McGill University, Montréal, QC, Canada;}2_McGill

University Health Centre, Montréal, QC, Canada

5 p.m. Adjourn

5:30–6:30 p.m. Exhibit Hall Grand Opening/Welcome Reception

7–9 p.m. Networking Reception

FRIDAY, OCTOBER 9, 2009

The Post Prostatectomy Bridge: Tissue Preservation after Radical Pelvic Surgery

Sponsored by VIVUS, Inc.

6:30–8 a.m. 5K Run/Walk

7:30–7:45 a.m. Best-of-Poster Sessions

Presented by moderators of previous day’s poster sessions

7:45–8:45 a.m. Plenary Session III: Prize Winning Essays

8:45–9:45 a.m. Plenary Session IV

8:45 a.m. PSA Screening

Eric A. Klein

Cleveland Clinic, Cleveland, Ohio, United States

Francesco Montorsi

Universitá Vita Salute, Milan, Italy

9:45–10:15 a.m. Break in Exhibit Hall

10:15 a.m.–Noon Concurrent Poster Sessions

10:15–10:45 a.m. View Posters

10:45–11 a.m. Welcome and Introduction

11 a.m.–Noon Moderated Poster Session V: Pediatric Urology

11 a.m. P67. TIP Urethroplasty in Primary Hypospadias Repair: A Series of 161 Patients

Marie-Pier Deschênes Rompré, Katherine Moore, Stéphane Bolduc

Laval University, Québec, QC, Canada

11:03 a.m. P68. Assessing Ureteropelvic Junction Obstruction (UPJO) Using Original Renographic Criteria for a Decade Proves to be Reliable

J. Letendre, D. Barrieras, A.M. Houle, K. Keu, R. Lambert, S. Turpin, J. Franc-Guimond

CHU Sainte-Justine, Montréal, QC, Canada

11:06 a.m. P69. Study Comparing the Applicability of Dorsal Lumbotomy in Older Children

Jonathan Cloutier, Nadim Haidar, Marie-Pier Rompré, Maryse Grimard, Stephane Bolduc

11:09 a.m. P70. Dye-Assisted Lymphatic-Sparing Laparoscopic Varicocelectomy in Children: Initial Experience

Waleed Eassa, Mohammed El-Sherbiny, Roman Jednak, John-Paul Capolicchio

Montréal Children’s Hospital, Montréal, QC, Canada

11:12 a.m. P71. Study on Hydrophilic-Coated Catheter Appreciation in a Pediatric Population

Andréanne Boucher, Jonathan Cloutier, Sylvie Lebel, Micheline Hamel, Pascale Lamontagne, Stéphane Bolduc

11:15 a.m. P72. Solifenacin for Overactive Bladder in Children: A Prospective Open-Label Study

Stéphane Bolduc, Katherine Moore

CHUL, Québec, QC, Canada

11:18 a.m. P73. Percutaneous Management of Urolithiasis in Children and Adolescents with Spinal Cord Lesions

Bishoy A. Gayed, Marc C. Smaldone, Michael C. Ost

11:21 a.m. P74. Ethical Considerations in the Management of Cryptorchidism in the Profoundly Disabled

Eric A. Singer, Danielle R. Wendel, Nadia A. Awad, Richard A. Demme, Jane Greenlaw, William C. Hulbert, Jr., Robert A. Mevorach, Ronald Rabinowitz

University of Rochester Medical Center, Rochester, NY, United States

(7)

CUAJ • October 2009 • Volume 3(5Suppl3) S127

11:24 a.m. P75. High Cost, Minimal Benefit: A Cost-Benefit Analysis of Ultrasound in the Management of Adolescent Varicocele

Adam Walker, Barry Kogan

Albany Medical Center, Albany, NY, United States

11:27 a.m. P76. Can We Avoid Removing the Adrenal Gland at the Time of Radical Nephrectomy in Children with Wilms Tumor?

Armando J. Lorenzo1_{, Katherine Moore}1_{, Bruno}

Leslie1_{, Stephane Bolduc}2

1_{Hospital for Sick Children, Toronto, ON, Canada;} 2_{Centre Hospitalier Universitaire de Québec,}

Québec, QC, Canada

11:30 a.m. P77. Are There Risk Factors for Perinatal Torsion?

Lei Chu, Michael C. Ost, Steven G. Docimo, Mark F. Bellinger, Francis X. Schneck

11:33 a.m. P78. Evaluation of Hydronephrosis in Pediatric Kidney Transplants and its Clinical Relevance

Lei Chu, Bruce L. Jacobs, Michael C. Ost, Mark F. Bellinger, Steven G. Docimo, Francis X. Schneck

11:36 a.m. P79. Retroperitoneoscopic Nephrectomy in Children on Peritoneal Dialysis: The Gold Standard

Konrad M. Szymanski, Martin Bitzan, John-Paul Capolicchio

11:39 a.m. P80. Long-Term Functional Outcome After Primary Repair of Classic Bladder Exstrophy

Waleed Eassa, Roman Jednak, John Paul Capolicchio, Mohamed T. El Sherbiny

11:42 a.m. P81. In vitro_{Reconstruction of an Autologous, Watertight}

and Resistant Vesical Equivalent

Stéphane Bolduc

11:45 a.m. P82. Serosal Lined Extramural Tunnel Principle in the Creation of a Catheterizable Channel in Bladder Augmentation: The Video

Mohamed T. El Sherbiny, Waleed Eassa

11:48 a.m. P83. Dextranomer/Hyaluronic Acid Copolymer (Deflux) Injections in a Teaching Center: The Real Picture

Julie Franc-Guimond, Julien Letendre, Diego Barrieras, Anne-Marie Houle

CHU Sainte-Justine, Montréal, QC, Canada

11:51 a.m. P84. The Anterior Approach to Retroperitoneoscopic Adrenalectomy in Children

Waleed Eassa, Mohammed El-Sherbiny, Roman Jednak, John-Paul Capolicchio

Noon Adjourn

11a.m.–Noon Moderated Poster Session VI: Oncology

11 a.m. P85. Temporal Stage and Grade Migration in Surgically-Treated Patients with Upper Urinary Tract Transitional Cell Carcinoma

Giovanni Lughezzani1_{, Claudio Jeldres}1_{, Hendrik}

Isbarn1_{, Maxine Sun}1_{, Shahrokh F. Shariat}1_{, Daniel}

Liberman1_{, Hugues Widmer}1_{, PhilippeArjane}1_,

Daniel Pharand1_{, Markus Graefen}2_{, Paul Perrotte}1_,

Francesco Montorsi3_{, Pierre I. Karakiewicz}1

1_{University of Montréal, Montréal, QC, Canada;} 2_{Prostate Cancer Center Hamburg-Eppendorf,}

Hamburg, Germany; 3_{Vita-Salute University, Milan,}

Italy

11:03 a.m. P86. An Assessment of the Prognostic Significance of Tumor Grade in Patients with Upper Urinary Tract Transitional Cell Carcinoma: A Population-Based Study

Pharand1_{, Hugues Widmer}1_{, Philippe Arjane}1_,

Markus Graefen2_{, Francesco Montorsisale}3_{, Paul}

Perrotte1_{, Pierre I. Karakiewicz}1

Italy

11:06 a.m. P87. Segmental Ureterectomy Can Safely Be Performed in Patients with Ureteral Upper Tract Transitional Cell Carcinoma

Daniel Liberman1_{, Claudio Jeldres}1_{, Giovanni}

Lughezzani1_{, Hendrik Isbarn}1_{, Maxine Sun}1_,

Shahrokh F. Shariat1_{, Daniel Pharand}1_{, Philippe}

Arjane1_{, Margit Fisch}2_{, Markus Graefen}2_{, Francesco}

Hamburg, Germany; 3_{Vita-Salute San Raffaele, Milan,}

Italy

11:09 a.m. P88. The Impact of Tumor Stage and Nodal Metastases on Cancer Specific Mortality in Patients with Upper Urinary Tract Transitional Cell Carcinoma: Results from a Population-Based Study

Markus Graefen2_{, Paul Perrotte}1_{, Francesco}

Montorsi3_{, Pierre I. Karakiewicz}1

Italy

11:12 a.m. P89. Patients with Renal Pelvis Upper Tract Transitional Cell Carcinoma Have Significantly Worse Cancer-Specific Survival than Patients with Ureteral Primaries

Daniel Liberman1_{, Claudio Jeldres}1_{, Al’a Abdo}1_{, Fred}

Saad1_{, Francois Benard}1_{, Luc Valiquette}1_{, Francesco}

1_{University of Montréal, Montréal, QC, Canada;} 2_{Vita-Salute San Raffaele, Milan, Italy}

11:15 a.m. P90. A Population-Based Assessment of Perioperative Mortality After Nephroureterectomy for Upper-Tract Transitional Cell Carcinoma

Claudio Jeldres1_{, Maxine Sun}1_{, Hendrik Isbarn}1_,

(8)

S128 CUAJ • October 2009 • Volume 3(5Suppl3) Liberman1_{, Hugues Widmer}1_{, Daniel Pharand}1_,

Philippe Arjane1_{, Markus Graefen}2_{, Francesco}

Italy

11:18 a.m. P91. Gender-Related Differences in Patients with Upper Urinary Tract Transitional Cell Carcinoma: Results from the Surveillance, Epidemiology and End Results Database

Valerie Deslauriers1_{, Giovanni Lughezzani}1_{, Hendrik}

Isbarn1_{, Claudio Jeldres}1_{, Maxine Sun}1_{, Shahrokh}

F. Shariat1_{, Daniel Pharand}1_{, Hugues Widmer}1_,

Philippe Arjane1_{, Markus Graefen}2_{, Paul Perrotte}1_,

Italy

11:21 a.m. P92. Significance of Positive Bladder Cuff in Nephroureterectomy Specimen in Patients with Upper Urinary Tract Urethelial Tumors

Yasser Osman, Mohamed El Awady, Mahmoud Kenawy, Mohamed Gaballa, El-Housseiny Ibrahiem

Mansoura Urology and Nephrology Center, Mansoura, Egypt

11:24 a.m. P93. Intravesical Recurrence Post-Nephroureterctomy for Upper Urinary Tract-Urothelial Carcinoma, Analysis of Risk Factors

Yasser Osman, Mohamed El Awady, Mahmoud Kenawy, Mohamed Gaballa, El-Housseiny Ibrahiem

Mansoura Urology and Nephrology Center, Mansoura, Egypt

11:27 a.m. P94. Development and External Validation of a Highly Accurate Nomogram for the Prediction of Cancer-Specific Mortality After Nephroureterectomy for Upper Tract Transitional Cell Carcinoma

Claudio Jeldres1_{, Maxine Sun}1_{, Hendrik Isbarn}1_,

Giovanni Lughezzani1_{, Shahrokh F. Shariat}1_{, Daniel}

Francesco Montorsi2_{, Paul Perrotte}1_{, Pierre I.}

Karakiewicz1

11:30 a.m. P95. Prognostic Value of Insulin-Like Growth Factor-I and Binding Proteins 2 and 3 in Patients Treated with Radical Prostatectomy

Geneviève Nadeau, François Harel, Pierre Douville, Yves Fradet, Louis Lacombe

11:33 a.m. P96. Cesium-131 vs. Iodine-125 Implants for Prostate Cancer: Evaluation of Early PSA Response

Jeffrey J. Tomaszewski, Marc C. Smaldone, Ronald M. Benoit

11:36 a.m. P97. Treatment and Outcomes of Bladder Cancer Following Solid Organ Transplantation

Jeffrey J. Tomaszewski, Jeff Larson, Marc C. Smaldone, Stephen V. Jackman

11:39 a.m. P98. Toremifene 80 mg Phase 3 Trial in Men on ADT Demonstrates Improvement in Gynecomastia Compared to Placebo

Hugh Fisher1_{, Ronald Kaufman}1_{, Ronald A. Morton}2

1_{The Urological Institute of Northeastern New York,}

Albany, NY, United States; 2_{GTx, Inc, Memphis,}

TN, United States

11:42 a.m. P99. Retroperitoneal Lymph Node Dissection of Post-Chemotherapy Residual Masses for Metastatic Germ Cell Testicular Cancer

Murilo A. Luz, Simon Tanguay, Wassim Kassouf, Ahmed F. Kotb, Saad Aldousari, Armen G. Aprikian

11:45 a.m. P100. Comparison of the Costs of Active Surveillance vs. Radical Prostatectomy

Anthony T. Corcoran, Ronald M. Benoit

11:48 a.m. P101. Phase III Trial in Men on ADT Demonstrates a Reduction in Hot Flashes in Men on Toremifene 80 mg Compared to Placebo

Jeff Gingrich1_{, Philip Aliotta}2_{, Ronald A. Morton}3

1_{Pittsburgh VA Health Care Center, Pittsburgh, PA,}

United States; 2_{Center for Urologic Reseach of WNY,}

LLC, Williamsville, NY, United States; 3_{GTx, Inc,}

Memphis, TN, United States

Noon Adjourn

1:15–3 p.m. Plenary Session V

1:15 p.m. Welcome and Introduction

1:20 p.m. Prostate Cancer Chemo Prevention

Eric A. Klein

Cleveland Clinic, Cleveland, Ohio,United States

2:05 p.m. AUA Course of Choice: Interstitial Cystitis/Painful Bladder Syndrome and Related Conditions: Practical Management Strategies

Robert Moldwin

Smith Institute of Urology, New Hyde Park, New York

3:15–5 p.m. Concurrent Poster Sessions

3:15–3:45 p.m. View Posters

3:45–4 p.m. Welcome and Introduction

4–5 p.m. Moderated Poster Session VII: General Urology

4 p.m. P102. Research in Urology: A National Survey on Attitudes and Experience of Research in Urology Residency

Jason Izard, D. Robert Siemens

(9)

4:03 p.m. P103. Suprasacral Spinal Cord Injury Patients Managed by Reflex Voiding: Characterization of our Cohort

John M. Rutkowski, Kevan Pranikoff, Jan Capuana

University at Buffalo, Buffalo, NY, United States

4:06 p.m. P104. Surgical Treatment of Bladder Outlet Obstruction Improves Outcome in Male Interstitial Cystitis

Roger E. Vega

UPMC St. Margaret, Pittsburgh, PA, United States

4:09 p.m. P105. Office-Based Urotelehealth— Bringing Urology Health Care Near to Home: A Work in Progress

Emmanuel O. Abara1_{, Sylvia Naughton}2_{, Oge}

Abara3_{, Rob Williams}4

1_{York Central Hospital, Richmond Hill, ON, Canada;} 2_{Ontario Telemedicine Network, Barrie, ON,}

Canada; 3_{University of Toronto, Toronto, ON,}

Canada; 4_{Ontario Telemedicine Network, Timmins,}

ON, Canada

4:12 p.m. P106. An Open-Label, Multi-Center Pharmacokinetic Study of Uracyst® _{400 mg Following a Single Bladder}

Instillation in Subjects with Interstitial Cystitis/Painful Bladder Syndrome

Keshava N. Kumar1_{, Blair R. Egerdie}2_{, Weining}

Volinn1_{, Lawrence Hill}1_{, Gary Hoel}

1_{Watson Laboratories, Inc, Salt Lake City, UT, United}

States; 2_{Urology Associates/Urology Medical}

Research, Kitchner, ON, Canada

4:15 p.m. P107. Utility of an Ambulatory Pessary Trial to Unmask Occult Stress Urinary Incontinence

Bilal Chughtai, Elise J. B. De

4:18 p.m. P108. The Longitudinal Effects on Penile Oxygen Saturation from a Prospective Randomized Study of the Nightly Use of Intraurethral Alprostadil vs. Sildenafil Following Nerve-Sparing Radical Prostatectomy (NSRP)

Andrew R. McCullough, Brianne Goodwin, Herbert Lepor

New York University School of Medicine, New York, NY, United States

4:21 p.m. P109. The Impact of Clomiphene Citrate on Severe Idiopathic Oligospermia

Jennifer Gordetsky, Jeanne O’Brien

4:24 p.m. P110. A Comparison Between Composix™-Based Slings, Tension Free Vaginal Tapes Tvt™ and Transobturator Tapes Tvt-o™ at a Median Follow-Up of 24 months

Nadim H. Haidar, Katherine Moore, Rachel Sweenor, Mireille Grégoire

4:27 p.m. P111. Clinical Phenotyping of Urologic Chronic Pelvic Pain Syndromes (UCPPS): Validation of the “Snowflake Hypothesis”

J. Curtis Nickel1_{, Daniel Shoskes}2

1_{Queen’s University, Kingston, ON, Canada;} 2_{Cleveland Clinic, Cleveland, OH, United States}

4:30 p.m. P112. Mid-Term Results of Pelvic Organ Prolapse Repair Using a Transvaginal Mesh: The Sherbrooke Experience

Louis-Olivier Gagnon, Le-Mai Tu

Centre Hospitalier Universitaire de Sherbrooke (CHUS), Sherbrooke, QC, Canada

4:33 p.m. P113. An Autologous Tissue-Engineered Endothelialized Graft: A Possible Option in the Surgical Correction of Peyronie’s Disease

Annie Imbeault, Geneviève Bernard, Gabrielle Ouellet, Sara Bouhout, Stéphane Bolduc

Laboratoire d’Organogénèse expérimentale/LOEX, CHA, Hôpital du St-Sacrement, Québec, QC, Canada

4:36 p.m. P114. Chondroitin Sulfate is a Promising Therapy for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)

J. Curtis Nickel1_{, Blair Egerdie}2_{, Anthony Skehan}3_,

Karen Irvine-Bird1_{, Joe Downey}1

1_{Queen’s University, Kingston, ON, Canada;} 2_{Urology Associates/Urology Medical Research,}

Kitchener, ON, Canada; 3_{Urology, Thunder Bay,}

ON, Canada

4:39 p.m. P115. MRI-Guided Transurethral Ultrasound Therapy with Real Time Thermal Mapping: Initial Studies

Laurence Klotz, Kashif Siddiqui, Rajif Chopra, Michael Bronskill.

Sunnybrook HSC, Toronto, ON, Canada.

4:42 p.m. P116. Recovery of Erectile Function Following Nerve-Sparing Radical Prostatectomy After Penile Rehabilitation with Nightly Intraurethral Alprostadil vs. Sildenafil Citrate

Andrew R. McCullough1_{, Herbert Lepor}1_{, Run}

Wang2_{, Kristopher R. Wagner}3_{, Wayne J. G.}

Hellstrom4_{, Jason D. Engel}5

1_{New York University School of Medicine, New}

York, NY, United States; 2_{University of Texas–MD}

Anderson Cancer Center and University of Texas Medical School, Houston, TX, United States; 3_Texas

A & M Health Science Center College of Medicine, Temple, TX, United States; 4_{Tulane University, New}

Orleans, LA, United States; 5_{George Washington}

University, Washington DC, United States

4:45 p.m. P117. Provider Recommendation and Treatment Choice

Willie Underwood, III1_{, Heather Orom}2_{, Brady}

West3_{, Jay Fowkes}4

States; 2_{University of Buffalo, Buffalo, NY, United}

States; 3_{University of Michigan, Ann Arbor, MI,}

United States; 4_{Vanderbilt University School of}

Medicine, Nashville, TN, United States

4:48 p.m. P118. Optimization of the Nanolantern™ Assay for Rapid Detection of Common Urinary Tract Pathogens

Jennifer G. Rothschild, Christopher M. Strohsahl, Ganesh S. Palapattu, Benjamin L. Miller

5 p.m. Adjourn

4–5 p.m. Moderated Poster Session VIII: Kidney Cancer

(10)

S130 CUAJ • October 2009 • Volume 3(5Suppl3)

4 p.m. P119. Withdrawn

4:03 p.m. P120. Role of Biopsy in the Management of Small Renal Masses

Bilal Chughtai, Ronald P. Kaufman Jr., Hugh A. G. Fisher, Gary Sisken, Badar Mian

4:06 p.m. P121. The Impact on Renal Function After Partial vs. Radical Nephrectomy for Renal Cell Carcinoma: A Systematic Review

Brian Kim1_{, Luke Lavallee}1_{, Dean Fergusson}2_{, Ilias}

Cagiannos1

1_{University of Ottawa, Ottawa, ON, Canada;} 2_{Ottawa Health Research Institute, Ottawa, ON,}

Canada

4:09 p.m. P122. Factors Predicting Renal Impairment on Long-Term Follow-Up, Following Partial Nephrectomy: McGill 10 Years Experience

Ahmed F. Kotb, Tamer H. Abou Youssif, Murilo A. Luz, Armen Aprikian, Wassim Kassouf, Fadi Brimo, Simon Tanguay

McGill University Health Centre, Montréal General Hospital, Montréal, QC, Canada

4:12 p.m. P123. Preliminary Report of a Pilot Study of Neoadjuvant Sunitinib for Clinical M0 Renal Cell Carcinoma

Nicholas Hellenthal, Joel Gajewski, Marcus Sikorski, Hyung Kim

Roswell Park Cancer Institute, Buffalo, NY, United States

4:15 p.m. P124. Tumor Size is a Determinant of the Rate of Synchronous Metastases in Patients with T1 Stage Renal Cell Carcinoma

Isbarn1_{, Paul Perrotte}1_{, Shahrokh F. Shariat}1_{, Maxine}

Sun1_{, Hugues Widmer}1_{, Philippe Arjane}1_{, Francois}

Peloquin1_{, Saniel Pharand}1_{, Jean-Jaques Patard}2_,

Markus Graefen3_{, Francesco Montorsi}4_{, Pierre I.}

Karakiewicz1

1_{University of Montréal, Montréal, QC, Canada;} 2_{Rennes University Hospital, Rennes, France;} 3_{Prostate Cancer Center Hamburg-Eppendorf,}

Italy

4:18 p.m. P125. Conditional Survival Predictions After Nephrectomy for Renal Cell Carcinoma

Claudio Jeldres1_{, Nazareno Suardi}1_{, Umberto}

Capitanio1_{, Hendrik Isbarn}1_{, Paul Perrotte}1_{, Vincenzo}

Ficarra2_{, Richard Zigeuner}3_{, Jacques Tostain}4_{, Arnaud}

Mejean5_{, Luca Cindolo}6_{, Allan J. Pantuck}7_{, Arie S.}

Belldegrun7_{, Laurent Zini}8_{, Alexandre de la Taille}9_,

Denis Chautard10_{, Jean-Luc Descotes}11_{, Shahrokh}

F. Shariat1_{, Antoine Valeri}12_{, Peter F. A. Mulders}13_,

Herve Lang14_{, Eric Lechevallier}15_{, Jean-Jacques}

Patard16_{, Pierre I. Karakiewicz}1

1_{University of Montréal, Montréal, QC, Canada;} 2_{University of Padua, Padua, Italy;} 3_Medical

University of Graz, Graz, Austria; 4_University

Hospital of Saint-Etienne, Saint-Etienne, France;

5_{Necker Medical School, Paris, France;}6_{G. Rummo}

Hospital, Benevento, Italy; 7_{David Geffen School}

of Medicine, Los Angeles, CA, United States;

8_{University of Lille, Lille, France;}9_{Henri Mondor}

University Hospital, Creteil, France; 10_University

of Angers, Angers, France; 11_{Medical University of}

Grenoble, Grenoble, France; 12_{Brest University}

Medical School, Brest, France; 13_{Radboud University,}

Nijmegen, Netherlands; 14_{University of Toulouse,}

Toulouse, France; 15_{Marseille University, Marseille,}

France; 16_{Rennes University Hospital, Rennes, France}

4:21 p.m. P126. Prognostic Significance of Lymph Node Invasion in Patients with Metastatic Renal Cell Carcinoma: A Population-Based Perspective

Giovanni Lughezzani1_{, Umberto Capitanio}2_{, Claudio}

Jeldres1_{, Hendrik Isbarn}1_{, Shahrokh F. Shariat}1_,

Philippe Arjane1_{, Hugues Widmer}1_{, Paul Perrotte}1_,

1_{University of Montréal, Montréal, QC, Canada;} 2_{Vita-Salute University, Milan, Italy}

4:24 p.m. P127. Pushing the Limits of Partial Nephrectomy: Time to Pause?

Claudio Jeldres1_{, Maxime Crepel}1_{, Umberto}

Capitanio1_{, Paul Perrotte}1_{, Hendrik Isbarn}1_{, Giovanni}

Lughezzani1_{, Maxine Sun}1_{, Shahrokh F. Shariat}1_,

Hugues Widmer1_{, Markus Graefen}2_{, Francesco}

Montorsi3_{, Pierre I. Karakiewicz}1

Italy

4:27 p.m. P128. A Population-Based Analysis of the Rate of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in the United States

Daniel Liberman1_{, Claudio Jeldres}1_{, Sara}

Baillargeon-Gagne1_{, Hendrik Isbarn}1_{, Umberto Capitanio}1_,

Shahrokh F. Shariat1_{, Maxine Sun}1_{, Giovanni}

Lughezzani1_{, Paul Perrotte}1_{, Francesco Montorsi}2_,

Markus Graefen3_{, Pierre I. Karakiewicz}1

Vita-Salute San Raffaele, Milan, Italy; 3_{Prostate Cancer}

Center Hamburg-Eppendorf, Hamburg, Germany

4:30 p.m. P129. Tumor Necrosis is not an Informative Marker of Cancer-Specific Mortality in Patients with all Stages of Renal Cell Carcinoma

Radoslav Krouchev1_{, Hendrik Isbarn}1_{, Jean- Jacques}

Patard2_{, Claudio Jeldres}1_{, Maxine Sun}1_{, Giovanni}

Lughezzani1_{, Paul Perrotte}1_{, Pierre I. Karakiewicz}1

1_{University of Montréal, Montréal, QC, Canada;} 2_{Rennes University Hospital, Rennes, France}

4:33 p.m. P130. Can Renal Mass Biopsy Assessment of Tumor Grade Be Safely Substituted with a Predictive Model?

Daniel Liberman1_{, Claudio Jeldres}1_{, Maxine Sun}1_,

Alexandre de la Taille2_{, Jacques Tostain}2_{, Antoine}

Valeri2_{, Luca Cindolo}3_{, Vincenzo Ficarra}4_{, Walter}

Artibani5_{, Richard Zigeuner}2_{, Arnaud Mejean}2_{, Jean}

Luc Descotes2_{, Eric Lechevallier}2_{, Peter F. Mulders}2_,

Francesco Montorsi6_{, Paul Perrotte}1_{, Jean-Jacques}

Patard2_{, Pierre I. Karakiewicz}1

1_{University of Montréal, Montréal, QC, Canada;} 2_{Lille University Hospital, Lille, France;}3_Vita-Salute

San raffaele, Milan, Italy; 4_{Vita-Salute San Raffaele,}

(11)

4:36 p.m. P131. For T1an0m0 Renal Cell Carcinoma, Nephron-Sparing Surgery has the Same Cancer Control than Radical Nephrectomy: A Population-Based Assessment

Salima Ismail1_{, Claudio Jeldres}1_{, Maxime Crepel}1_,

Hendrik Isbarn1_{, Giovanni Lughezzani}1_{, Maxine}

Sun1_{, Daniel Liberman}1_{, Shahrokh F. Shariat}1_{, Daniel}

Pharand1_{, Phillippe Arjane}1_{, Francesco Montorsi}2_,

Paul Perrotte1_{, Pierre I. Karakiewicz}1

4:39 p.m. P132. A Comparative Population-Based Analysis of the Rate of Partial vs. Radical Nephrectomy for Clinical Localized Renal Cell Carcinoma

Salima Ismail1_{, Sara Baillargeon-Gagne}1_{, Claudio}

Jeldres1_{, Giovanni Lughezzani}1_{, Hendrik Isbarn}1_,

Umberto Capitanio1_{, Shahrokh F. Shariat}1_{, Maxime}

Crepel1_{, Maxine Sun}1_{, Hugues Widmer}1_{, Philippe}

Arjane1_{, Jean-Jacques Patard}2_{, Paul Perrotte}1_,

Francesco Montorsi3_{, Markus Graefen}4_{, Pierre I.}

Karakiewicz1

1_{University of Montréal, Montréal, QC, Canada;} 2_{Rennes University Hospital, Rennes, France;}3

Vita-Salute San Raffaele, Milan, Italy; 4_{Martiniclinic,}

4:42 p.m. P133. Nephron-Sparing Surgery is Equally Effective to Radical Nephrectomy for T1bN0M0 Renal Cell Carcinoma: A Population-Based Assessment.

Nawar Hanna1_{, Maxime Crepel}1_{, Claudio Jeldres}1_,

Paul Perrotte1_{, Umberto Capitanio}1_{, Hendrik Isbarn}1_,

Shahrokh F. Shariat1_{, Giovanni Lughezzani}1_{, Maxine}

Sun1_{, Philippe Arjane}1_{, Hugues Widmer}1_{, Markus}

Graefen2_{, Francesco Montorsi}3_{, Jean-Jacques Patard}4_,

Pierre I. Karakiewicz1

1_{University of Montréal, Montréal, QC, Canada;} 2_{Martiniclinic, Prostate Cancer Hamburg-Eppendorf,}

Italy; 4_{Rennes University Hospital, Rennes, France}

4:45 p.m. P134. Simplified Fuhrman Grade is Equally Informative to the Conventional Fuhrman Grade: A Population-Based Analysis

Maxine Sun1_{, Giovanni Lughezzani}1_{, Claudio}

Jeldres1_{, Hendrik Isbarn}1_{, Philippe Arjane}1_{, Hugues}

Widmer1_{, Daniel Pharand}1_{, Shahrokh F. Shariat}1_,

Francesco Montorsi2_{, Paul Perrotte}1_{, Pierre I.}

Karakiewicz1

5 p.m. Adjourn

5:30–6:30 p.m. Residents’ Reception

7–10 p.m. Cirque Éloize Fun Night

SATURDAY, OCTOBER 10, 2009

7:30–8:30 a.m. Annual Business Meeting

7:30–8:30 a.m. Residents’ Breakfast

How to Select a Urology Fellowship Program

Shahrokh Shariat

Dallas, Texas, United States

8:30–8:45 a.m. Best-Of-Poster Session

Presented by moderators of previous day’s poster sessions

8:45–9:30 a.m. Slotkin Lecture Sun, Light and Shadows

Sir Phillip G. Ransley

Consultant Pediatric Urologist, London, England

9:30–10:15 a.m. Plenary Session VI

9:35 a.m. Androgen Deprivation Therapy

Edward M. Messing

University of Rochester, Rochester, New York, United States

10:15–10:45 a.m. Break

10:45 a.m. Plenary Session VII

10:50 a.m. Urinary Obstruction from the Cradle to the Grave

Sir Phillip Ransley

Consultant Pediatric Urologist, London, England

11:20 a.m. Stress Urinary Incontinence and Unstable Bladder

Martine Jolivet-Tremblay

University of Montréal, Montréal, Québec, Canada

Noon Adjourn

12:30 p.m. Tennis Tournament

6:30–10 p.m. President’s Banquet